Rethinking Clinical Trials

JUNE 26, 2023

Pérez-Stable, MD, Director of the National Institute on Minority Health and Health Disparities (NIMHD), shared his thoughts on national priorities for reducing health disparities and opportunities for clinical researchers to help promote health equity.

Research 130

Research Big Data Clinical Research Trials 130

pharmaphorum

FEBRUARY 1, 2022

Attendees will learn more about how an SCA was used at the design and execution phases in a recent study of new treatments for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) and will also receive an eBook ‘How to harness the potential of AI and real-world data for clinical research’. About the panel.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

pharmaphorum

MAY 25, 2021

The webinar explored the potential of the technology to process the vast amount of data languishing untapped in EHRs, while ensuring that patient data privacy and safety is maintained at all times. Ignacio is in demand as an international speaker at digital health, clinical research, science and technology events and congresses.

Big Data 135

Big Data Clinical Research Research Trials 135

Drug Discovery World

DECEMBER 20, 2022

According to a survey of 150 biotech and biopharma leaders by clinical research company PPD , leveraging new technologies (including mRNA and drug discovery platforms) is one of the greatest opportunity areas in clinical trials for 2023. . Novel therapeutic platforms will drive innovation . M&A activity will accelerate.

Drugs 52

Drugs Gene Editing Clinical Trials Clinical Trials 52

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

The Pharma Data

JANUARY 12, 2021

Akin to the NASA Deep Space Network, SYNERGY-AI OCTCC is a real time data and communication network between patients, sites, and pharmaceutical companies, with the Massive Bio AI-enabled engine orchestrating these stakeholders for successful operations.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

pharmaphorum

SEPTEMBER 16, 2022

Verily’s Immune Profiler platform is “a discovery engine consisting of proprietary immune profiling lab workflow, growing multi-omic database, and advanced analytical tools”. A notable issue with clinical trials is the homogeneity of the patient database.

Development 135

Development Research Drugs Clinical Trials 135